| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/13/2001 | US6201105 Amino acid sequence; treatment of septic shock and cachexia; diagnosis |
| 03/13/2001 | US6201104 Amino acid sequences of angiogenesis-inhibiting protein receptor; drug screening; isolation of angiogenesis related proteins |
| 03/13/2001 | US6201103 Peptide nucleic acid incorporating a chiral backbone |
| 03/13/2001 | US6200960 Inhibition of proliferation of cells |
| 03/13/2001 | US6200956 Nucleic acid-containing composition, preparation and use thereof |
| 03/13/2001 | US6200951 For detecting chitin, binding chitin, and treating fungal infections or for development of products useful for fungal infection therapy |
| 03/13/2001 | US6200813 Altering substrate specificity of polyketide synthase by isolating genomic dna fragments which encode acyltransferase domain, transforming cell having one fragment with other fragment for homologous recombination; antibiotics |
| 03/13/2001 | US6200812 Sequence alterations using homologous recombination |
| 03/13/2001 | US6200811 For making human immunodeficiency virus resistant cells; gene therapy |
| 03/13/2001 | US6200807 Antisense inhibition of SHP-2 expression |
| 03/13/2001 | US6200803 Preventing fungal contamination in cell culture by incubating cells in cell culture medium with either antisense oligonucleotide or ribozyme complementary to messenger rna of essential yeast genes |
| 03/13/2001 | US6200801 A polycation and a binding moiety of defined amino acid sequence capable of binding to a serpin enzyme complex receptor for targeted gene delivery; gene therapy; antisense agents |
| 03/13/2001 | US6200800 Defective moloney murine leukemia provirus used as retroviral vector for gene therapy and vaccines; has recognition sequence for elimination of proviral sequences for more accurate and safe use |
| 03/13/2001 | US6200799 Replication-defective recombinant virus includes promoter from human major intrinsic protein or human crystallin and an open reading frame of human ras, herpes simplex type i thymidine kinase, or non-phosphorylatable retinoblastoma |
| 03/13/2001 | US6200798 Defective recombinant adenoviruses with inactivated IVa2 gene |
| 03/13/2001 | US6200796 Nucleotide and amino acid sequences; recombinant production; treatment of urolithiasis and hyperoxaluria |
| 03/13/2001 | US6200795 Polypeptides having uroporphyrinogen decarboxylase activity and nucleic acids encoding same |
| 03/13/2001 | US6200792 For bread- or dough-improving composition; reduction in bitter taste of protein hydrolyzates |
| 03/13/2001 | US6200790 Vesicle transport associated proteins |
| 03/13/2001 | US6200788 β-ketoacyl-ACP synthetase II enzymes and genes coding for same |
| 03/13/2001 | US6200787 Phenylalanyl tRNA synthetase polypeptides from streptococcus pneumoniae |
| 03/13/2001 | US6200786 From valencene |
| 03/13/2001 | US6200785 L-lysine-producing corynebacteria and process for the preparation of l-lysine |
| 03/13/2001 | US6200782 Fusion proteins linked to nucleotide sequences; for the preferential adjustment of nucleotide sequences |
| 03/13/2001 | US6200780 Human interferon-ε(IFN-ε), a type I interferon |
| 03/13/2001 | US6200779 Nucleotide sequences which code protein associated with bacterial infection; for prevent of infections and associated defects |
| 03/13/2001 | US6200778 Genomic sequences for protein production and delivery |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200776 Polynucleotides encoding human sodium bicarbonate cotransporters |
| 03/13/2001 | US6200775 Nucleotide sequence coding a polypeptide associated with the diagnosis and treatment of infections |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200770 Protein kinase molecules and uses therefor |
| 03/13/2001 | US6200769 Mammalian CDP-diacylglycerol synthase |
| 03/13/2001 | US6200768 Detecting compounds efficient in the dissolution of an alzheimer's protein; incubate preferential protein with kinase, monitor helix formation, incubate with modulator and detect blocking action by modulator |
| 03/13/2001 | US6200763 Detecting cell expressing myeloid polypeptide; incubate cell with binding substance and detecting bound substance, presence of bound protein indicates cell expressing myeloid protein |
| 03/13/2001 | US6200759 Interaction trap assay, reagents and uses thereof |
| 03/13/2001 | US6200758 Detecting a psychological disorders; obtain biopsies, detect nucleotide sequence variation, presence of variation indicates psychological disorders |
| 03/13/2001 | US6200757 Preferential chain elongation of a primer; mix blocking agent and primers, heat mixture causing the blocking agent to irreversibly denature from primer and permit chain extension, recover preferential products |
| 03/13/2001 | US6200751 Cell preferential regulatory sequences; for the control of transcription from heterologous nucleotide sequences; for use in gene therapy |
| 03/13/2001 | US6200750 Mammalian homologous recombination activating sequences and method of identification and their use thereof |
| 03/13/2001 | US6200749 Ajusted nucleic acid sequence; for detection of genome adjustments and preferential genetic disorders |
| 03/13/2001 | US6200747 Method and kits for detection of fragile X specific, GC-rich DNA sequences |
| 03/13/2001 | US6200622 Frozen food product |
| 03/13/2001 | US6200606 Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| 03/13/2001 | US6200578 Genetic engineered polypeptide |
| 03/13/2001 | US6200577 Anti-herpesviral agents and assays therefor |
| 03/13/2001 | US6200576 Swine vesicular disease virus and mutant strains and preparation process and use thereof |
| 03/13/2001 | US6200567 An antibody that binds to the common beta c chain of the receptor for gm-csf, il-3 and il-5 |
| 03/13/2001 | US6200566 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 03/13/2001 | US6200560 Adeno-associated virus vectors for expression of factor VIII by target cells |
| 03/13/2001 | US6200304 Transfection system, its preparation and use in somatic gene therapy |
| 03/13/2001 | CA2125673C Dna structure-specific recognition protein and uses therefor |
| 03/13/2001 | CA1341203C Eukaryotic fusion proteins, containing interleukin-2 sequences |
| 03/11/2001 | CA2317058A1 New nucleotide sequences which code for the dapf gene |
| 03/08/2001 | WO2001016860A2 Artificial intelligence system for genetic analysis |
| 03/08/2001 | WO2001016597A1 In vitro transcription systems and uses |
| 03/08/2001 | WO2001016378A2 Chromosome-wide analysis of protein-dna interactions |
| 03/08/2001 | WO2001016377A2 Diagnostics and therapeutics for osteoporosis |
| 03/08/2001 | WO2001016374A2 Methods and reagents for in situ amplification |
| 03/08/2001 | WO2001016372A1 Methods of immobilizing ligands on solid supports and apparatus and methods of use therefor |
| 03/08/2001 | WO2001016370A1 Arrays with mask layers and methods of manufacturing same |
| 03/08/2001 | WO2001016369A2 Uv excitable fluorescent energy transfer dyes |
| 03/08/2001 | WO2001016366A2 Template-dependent nucleic acid polymerization using oligonucleotide triphosphates building blocks |
| 03/08/2001 | WO2001016365A1 Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids |
| 03/08/2001 | WO2001016362A2 Fatty acid desaturase gene from plants |
| 03/08/2001 | WO2001016353A1 Nucleic acid sequences encoding cell wall-degrading enzymes and use to engineer resistance to fusarium and other pathogens |
| 03/08/2001 | WO2001016350A1 Method for amplifying signal-flanking sequences from unknown genomic dna |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016344A1 Modified adenoviral fibre and uses thereof |
| 03/08/2001 | WO2001016343A1 Antibody dependent enhancement (ade) of alphavirus infection |
| 03/08/2001 | WO2001016342A1 Use of lentiviral vectors for antigen presentation in dendritic cells |
| 03/08/2001 | WO2001016341A1 Improved methods and means for retroviral gene delivery |
| 03/08/2001 | WO2001016340A1 Flax seed specific promoters |
| 03/08/2001 | WO2001016339A1 Use of arabinogalactan protein fusion constructs in a method of expressing proteins and peptides in plants |
| 03/08/2001 | WO2001016338A2 Production of cellulase in plastids of transgenic plants |
| 03/08/2001 | WO2001016337A1 Stereostructure of decarbamylase and method of using the same |
| 03/08/2001 | WO2001016336A1 Human calcium dependent proteases and polynucleotides encoding the same |
| 03/08/2001 | WO2001016335A2 Stromelysin-homologous novel mmp-27 matrix metalloproteinase |
| 03/08/2001 | WO2001016334A2 Human hydrolytic enzymes |
| 03/08/2001 | WO2001016333A1 Methods for purifiying dna polymerases |
| 03/08/2001 | WO2001016332A1 Gene encoding protein participating in signal transduction of cytokinin |
| 03/08/2001 | WO2001016331A1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 03/08/2001 | WO2001016330A2 Prevention of affections associated with porcine circovirus-2 |
| 03/08/2001 | WO2001016329A2 Phage resistant streptococcus thermophilus |
| 03/08/2001 | WO2001016328A2 Method for the production of regular nanostructures |
| 03/08/2001 | WO2001016327A2 Method for producing a channel-forming protein |
| 03/08/2001 | WO2001016326A2 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 03/08/2001 | WO2001016325A2 Plant reproduction proteins |
| 03/08/2001 | WO2001016324A2 Methods and compositions of a novel serine protease inhibitor |
| 03/08/2001 | WO2001016323A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016322A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 03/08/2001 | WO2001016321A1 Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof |
| 03/08/2001 | WO2001016320A1 Isolated nona and decapeptides which bind to hla molecules, and the use thereof |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016318A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/08/2001 | WO2001016317A2 Polycyclic aromatic hydrocarbon induced molecules |
| 03/08/2001 | WO2001016316A1 Novel g protein-coupled receptor protein and dna thereof |
| 03/08/2001 | WO2001016315A1 sIGH AFFINITY CHOLINE TRANSPORTER |
| 03/08/2001 | WO2001016314A1 Iren protein, its preparation and use |
| 03/08/2001 | WO2001016313A1 Human gs protein regulator gene |